Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G2RY
|
|||
Former ID |
DNC014579
|
|||
Drug Name |
2-Amino-6-(indan-5-ylamino)-3H-pyrimidin-4-one
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H14N4O
|
|||
Canonical SMILES |
C1CC2=C(C1)C=C(C=C2)NC3=CC(=O)NC(=N3)N
|
|||
InChI |
1S/C13H14N4O/c14-13-16-11(7-12(18)17-13)15-10-5-4-8-2-1-3-9(8)6-10/h4-7H,1-3H2,(H4,14,15,16,17,18)
|
|||
InChIKey |
YUPQFUXJUXRXOG-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA topoisomerase (TOP) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. J Med Chem. 1986 May;29(5):676-81. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.